Science Fair Project Encyclopedia
Co-amoxiclav is the British Approved Name, in the British Pharmacopoeia, for the combination antibiotic containing amoxicillin and clavulanic acid. This name, unlike co-trimoxazole, has not been widely adopted internationally and the combination product is usually referred to by various names such as amoxicillin with clavulanic acid or amoxicillin+clavulanate or simply by the trade name. Co-amoxiclav is currently marketed by GlaxoSmithKline under the trade name Augmentin®.
The combination of amoxicillin, a β-lactam antibiotic; with clavulanic acid, a β-lactamase inhibitor; results in an antibiotic with an increased spectrum of action and restored efficacy against β-lactamase producing amoxicillin-resistant bacteria.
- Co-amoxiclav sensitive organisms
|PRODUCT||UPPER RESPIRATORY TRACT INFECTIONS||LOWER RESPIRATORY TRACT INFECTIONS||URINARY TRACT INFECTIONS||SKIN AND SOFT TISSUE INFECTIONS|
|AUGMENTIN 375||1 - 2 tablets 8 hourly||1 - 2 tablets 8 hourly||1 - 2 tablets 8 hourly||1 - 2 tablets 8 hourly|
|AUGMENTIN 625||1 tablet 8 hourly||1 tablet 8 hourly||1 tablet 8 hourly||1 tablet 8 hourly|
|AUGMENTIN BD||1 tablet 12 hourly||1 tablet 12 hourly||1 tablet 12 hourly||1 tablet 12 hourly|
The contents of this article is licensed from www.wikipedia.org under the GNU Free Documentation License. Click here to see the transparent copy and copyright details